Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 23 of 38 for:    cemiplimab

A Study of REGN2810 and Ipilimumab in Patients With Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03430063
Recruitment Status : Active, not recruiting
First Posted : February 12, 2018
Last Update Posted : April 8, 2019
Sponsor:
Collaborator:
Sanofi
Information provided by (Responsible Party):
Regeneron Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : April 30, 2020
Estimated Study Completion Date : April 30, 2020